Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

25751
1
Astrana Health, Inc. Astrana Health Reports 47% Revenue Growth to $2,034.5 Million in 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25752
1
Better Home & Finance Holding Co Better Home & Finance Reports $206.3M Net Loss in 2024, Revenue Increases by 50%

Via official filing (AI summary) | over 1 year ago | 0 comments

25753
1
ASSURED GUARANTY LTD Assured Guaranty Ltd. Reports $376 Million Net Income for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25754
1
Cohen & Co Inc. Cohen & Company Reports $129,000 Net Loss for 2024, Revenue Decrease of 4%

Via official filing (AI summary) | over 1 year ago | 0 comments

25755
1
Prime Medicine, Inc. Prime Medicine Reports $195.9 Million Net Loss for 2024, Highlights Strategic Developments

Via official filing (AI summary) | over 1 year ago | 0 comments

25756
1
Alpha Metallurgical Resources, Inc. Alpha Metallurgical Resources Reports $2.96 Billion Revenue for 2024, 14.8% Decrease

Via official filing (AI summary) | over 1 year ago | 0 comments

25757
1
Praxis Precision Medicines, Inc. Praxis Precision Medicines Reports $182.8 Million Net Loss for 2024, Highlights Funding and Clinical Developments

Via official filing (AI summary) | over 1 year ago | 0 comments

25758
1
Bit Digital, Inc Bit Digital Reports $28.3 Million Net Income for Fiscal Year 2024, Driven by Revenue Growth

Via official filing (AI summary) | over 1 year ago | 0 comments

25759
1
Akero Therapeutics, Inc. Akero Therapeutics Reports $252M Net Loss for 2024, Increases R&D Spending

Via official filing (AI summary) | over 1 year ago | 0 comments

25760
1
RECURSION PHARMACEUTICALS, INC. Recursion Pharmaceuticals Reports $463.6M Net Loss and $58.8M Revenue in 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25761
1
ANI PHARMACEUTICALS INC ANI Pharmaceuticals Reports $18.5 Million Net Loss Despite 26.2% Revenue Growth in 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25762
1
Apellis Pharmaceuticals, Inc. Apellis Pharmaceuticals Reports $197.8 Million Net Loss for 2024, Significant Revenue Growth Driven by SYFOVRE

Via official filing (AI summary) | over 1 year ago | 0 comments

25763
1
Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals Reports $130M Net Loss and $10.1M Revenue for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25764
1
Esperion Therapeutics, Inc. Esperion Therapeutics Reports $51.7 Million Net Loss for 2024, Improved from $209.2 Million in 2023

Via official filing (AI summary) | over 1 year ago | 0 comments

25765
1
scPharmaceuticals Inc. ScPharmaceuticals Reports $85.1 Million Net Loss for 2024, Despite Revenue Growth from FUROSCIX

Via official filing (AI summary) | over 1 year ago | 0 comments

25766
1
ProShares Trust II ProShares Trust II Reports Financial Performance for Year Ended December 31, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25767
1
Veradigm Inc. Veradigm Inc. Reports $86.4 Million Net Loss and $588 Million Revenue for 2022

Via official filing (AI summary) | over 1 year ago | 0 comments

25768
1
Silexion Therapeutics Corp Silexion Therapeutics Reports $16.5 Million Net Loss for 2024, Plans Phase 2/3 Trial for SIL204

Via official filing (AI summary) | over 1 year ago | 0 comments

25769
1
Infinera Corp Infinera Reports 12% Revenue Decline in Fiscal Year 2024, Anticipates Merger with Nokia

Via official filing (AI summary) | over 1 year ago | 0 comments

25770
1
HOOKIPA Pharma Inc. HOOKIPA Pharma Reports $43.5M Net Loss for 2024, Improved Revenue and Restructuring Plan

Via official filing (AI summary) | over 1 year ago | 0 comments

25771
1
Absci Corp Absci Corp. Reports $4.5 Million Revenue Decline and $103.1 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25772
1
Grayscale Ethereum Trust ETF Grayscale Ethereum Trust Reports $2.77B Gain in Ether Investments for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25773
1
Grayscale Ethereum Mini Trust ETF Grayscale Ethereum Mini Trust ETF Reports $32.8 Million Loss on Ether Investments

Via official filing (AI summary) | over 1 year ago | 0 comments

25774
1
Grayscale Bitcoin Mini Trust ETF Grayscale Bitcoin Mini Trust ETF Reports $980M Gain and Operational Changes for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25775
1
Olema Pharmaceuticals, Inc. Olema Pharmaceuticals Reports $129.4 Million Net Loss for 2024, Increased R&D Expenses

Via official filing (AI summary) | over 1 year ago | 0 comments